Abiopharma

🔍 Szot Matthew K (Executive)

Company: Cadrenal Therapeutics, Inc. (CVKD)

Report Date: 2025-08-27

Detailed Transactions and Holdings:

• Sold 1,600 shares of Common Stock at $13.995 per share (Direct)
  Date: 2025-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,733.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 400 shares of Common Stock at $14.0 per share (Direct)
  Date: 2025-08-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,333.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.00. The reporting person undertakes to provide to Cadrenal Therapeutics, Inc., any security holder of Cadrenal Therapeutics, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions, each at $14.000. The reporting person undertakes to provide to Cadrenal Therapeutics, Inc., any security holder of Cadrenal Therapeutics, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.